Landry Robert E bought REGN
February 2, 2024 · Form 4 insider transaction
Landry Robert E bought 400 shares of Regeneron Pharmaceuticals, Inc. at $378.98 per share, a transaction worth $151.6K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
400
Price
$378.98
Total value
$151.6K
InsiderLandry Robert E
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateFebruary 2, 2024
Filing dateFebruary 6, 2024
Shares owned after23,974
OwnershipDirect
10b5-1 planNo
AmendedNo